Understanding how RNA structures influence splicing regulation
Decoding global RNP topologies in splicing regulation
This study is exploring how our genes create different proteins through a process called alternative splicing, which is important for understanding diseases like cancer and neurodegeneration, with the hope of finding better, personalized treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11044189 on NIH RePORTER |
What this research studies
This research investigates the complex mechanisms of alternative splicing (AS), which is crucial for generating diverse proteins from our genes. By developing innovative technologies to analyze RNA structures and their interactions with proteins, the study aims to uncover how these processes are regulated in cells. This could lead to new insights into diseases caused by splicing mutations, such as neurodegeneration and cancer, ultimately paving the way for precision medicine approaches tailored to individual patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to splicing mutations, such as certain cancers, muscular dystrophies, or neurodegenerative diseases.
Not a fit: Patients without splicing-related conditions or those who do not have mutations affecting RNA processing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to targeted therapies for diseases linked to splicing mutations, improving treatment outcomes for affected patients.
How similar studies have performed: While the approach of analyzing RNA structures is innovative, similar methodologies have shown promise in other areas of molecular biology, suggesting potential for success in this novel application.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Lu, Zhipeng — University of Southern California
- Study coordinator: Lu, Zhipeng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.